PELP1: A novel therapeutic target for hormonal cancers - Wikidata - awgldk - TriplyDB

PELP1: A novel therapeutic target for hormonal cancers

PELP1: A novel therapeutic target for hormonal cancers

http://www.wikidata.org/entity/Q28267811

about

Inhibition of mTOR signaling reduces PELP1-mediated tumor growth and therapy resistance Regulation of rDNA transcription by proto-oncogene PELP1 PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer PELP1 oncogenic functions involve CARM1 regulation Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.Integrin-linked kinase 1: role in hormonal cancer progression.Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.PELP1 - A Key Mediator of Estrogen Signaling and Actions in the Brain.Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.

P2860

Q28237217-31F8E59D-CBE2-4F18-8198-B97E7A11A4A0 Q28241411-CA164108-CA0F-4788-A490-BD81168E85CF Q28251097-C8546C01-66AF-47EA-A373-5522B9183109 Q28261485-B059AA98-941D-401B-BACF-463854777948 Q28271388-9B7B5BC7-3029-48E3-AA2C-788004116ACF Q28287092-95812AAA-AA0E-4E2A-AE35-564C2C6FB186 Q28291526-3C8768C2-18F9-404A-B9F4-2B8A39C8A4D8 Q28297295-EE6230C6-26B9-4036-A528-7808807F4CEF Q28306753-20227B83-05C1-421A-9A2C-BC48D37CA0DE Q34622810-D2D019B7-65DF-4A18-9901-15355CCA968D Q36053869-39DEB300-C54B-4FCA-9883-5F97007F6F2C Q37060140-8D002C81-2FF7-4C94-B888-577B25E88569 Q37825335-92CBF02A-1994-4385-A9D3-1DDDEFC5782C Q38590446-BC4BB292-2D69-49E0-B4CB-90AEB37C1252 Q39293057-B5D408EE-BC45-420A-B371-A16FFB7EC732 Q47163309-D008F06F-62B0-46F5-BC45-EB73F7BAB44E

P2860

PELP1: A novel therapeutic target for hormonal cancers

http://www.wikidata.org/entity/Q28267811

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

PELP1: A novel therapeutic target for hormonal cancers

@ast

PELP1: A novel therapeutic target for hormonal cancers

@en

PELP1: A novel therapeutic target for hormonal cancers

@nl

type

label

PELP1: A novel therapeutic target for hormonal cancers

@ast

PELP1: A novel therapeutic target for hormonal cancers

@en

PELP1: A novel therapeutic target for hormonal cancers

@nl

prefLabel

PELP1: A novel therapeutic target for hormonal cancers

@ast

PELP1: A novel therapeutic target for hormonal cancers

@en

PELP1: A novel therapeutic target for hormonal cancers

@nl

P1433

Q28267811-1F2A549C-6207-498E-8D88-C68F45778838

P1476

Q28267811-CC92ACB1-C514-4C6B-B10A-5D8512D16AEF

P2093

Q28267811-4BE84ACF-C68D-4696-BA33-9C5D1A083E5E

Q28267811-6F05ED76-CFB7-476A-870C-8B3654005B20

Q28267811-F115D6B9-0199-4418-80F1-DA738478F2A3

P2860

Q28267811-01269E5E-2BA0-47B8-9EEB-C4DF0F80455F

Q28267811-050C03BF-1FB5-4EAF-95E0-C2AFCAEB4BD7

Q28267811-0C876140-F20E-43EA-A222-799875BCB42F

Q28267811-103AE63D-E091-4E27-886C-4ABDD7A1013F

Q28267811-19F1839F-2926-40FE-AA75-D5F9C279EEE7

Q28267811-200459B7-E3F5-453C-9E57-223A4F5AB978

Q28267811-24C9D1F0-DA12-4B0C-9ABE-4499894F4599

Q28267811-264F5C80-CE0D-4616-A855-34875FCCA71F

Q28267811-26C05F9F-5139-44E1-911A-62E08EF51825

Q28267811-30E710F0-C3F9-43B2-92EB-AAF80A2771B4

P304

Q28267811-9D46C4B6-C089-46EE-9E74-A0A2FFDBA7A4

P31

Q28267811-7CE6A979-90F9-4B5F-9A06-B390D6C846B3

P3181

Q28267811-21C8A311-2341-4F1F-B9AA-DE44B2F6A4D9

P356

Q28267811-6D79B2DF-AF22-4CF4-A327-3D082145897F

P407

Q28267811-0503743D-C09F-4101-9BF5-924869DA7E93

P433

Q28267811-816D9036-B8D5-4464-804A-E614E82684A1

P478

Q28267811-900F8CE8-2691-4F91-9E78-EA9B4B235940

P577

Q28267811-44304FE0-4ECF-4B9B-A470-4F0D21BC9DDF

P5875

Q28267811-49EAB3F7-B32E-4CB2-913D-093858A2A56E

P698

Q28267811-67A8DCC5-5A3D-47A0-B140-A7D2726ABC5D

P921

Q28267811-824A3B55-30AC-47BD-BB9B-FA22874D978D

Q28267811-BFB3FA1D-9C75-4E10-918D-20DB6351EE81

P932

Q28267811-035EBE7D-3567-470D-B85F-38BEFB2303A6

P3181

P356

P1433

P1476

PELP1: A novel therapeutic target for hormonal cancers

@en

P2093

Dimple Chakravarty

http://www.w3.org/2001/XMLSchema#string

Rajeshwar Rao Tekmal

http://www.w3.org/2001/XMLSchema#string

Ratna K Vadlamudi

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc

Upstream determinants of estrogen receptor-alpha regulation of metastatic tumor antigen 3 pathway.

Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein

NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR

MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions

Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha

Extranuclear coactivator signaling confers insensitivity to tamoxifen

The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype

The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling

P304

162-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

731240

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/IUB.287

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40691390

http://www.w3.org/2001/XMLSchema#string

P698

20014005

http://www.w3.org/2001/XMLSchema#string

P921

clinical chemistry

P932

2997573

http://www.w3.org/2001/XMLSchema#string